Lixte Biotechnology Holdings, Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Green day on Friday for Lixte Biotechnology Holdings, Inc.
(Updated on May 03, 2024)
The Lixte Biotechnology Holdings, Inc. stock price gained 0.274% on the last trading day (Friday, 3rd May 2024), rising from $2.88 to $2.89. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.47% from a day low at $2.87 to a day high of $3.00. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 737 more shares were traded than the day before. In total, 9 thousand shares were bought and sold for approximately $27.15 thousand.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.74 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 38.75% during the next 3 months and, with a 90% probability hold a price between $3.80 and $5.73 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
LIXT Signals & Forecast
Lixte Biotechnology Holdings, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lixte Biotechnology Holdings, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.00 and $3.06. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 02, 2024, and so far it has fallen -21.89%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Lixte Biotechnology Holdings, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $2.70 and $2.67. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Lixte Biotechnology Holdings, Inc. finds support just below today's level at $2.70. If this is broken, then the next support from accumulated volume will be at $2.67 and $2.21.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.129 between high and low, or 4.47%. For the last week, the stock has had daily average volatility of 6.62%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (LIXT) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Lixte Biotechnology Holdings, Inc. to open at $2.92, and during the day (based on 14 day Average True Range), to move between $2.61 and $3.17, which gives a possible trading interval of +/-$0.280 (+/-9.69%) up or down from last closing price. If Lixte Biotechnology Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 19.38% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.70 (6.75%) than the resistance at $3.31 (14.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Lixte Biotechnology Holdings, Inc. will release earnings BMO on Wednesday, May 08, 2024. We will update the financials statements for Lixte Biotechnology Holdings, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.59% in the first trading day after earnings release.
Is Lixte Biotechnology Holdings, Inc. stock A Buy?
The Lixte Biotechnology Holdings, Inc. stock holds several negative signals and despite the positive trend, we believe Lixte Biotechnology Holdings, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -4.671 Sell Candidate Unchanged
Predicted Opening Price for Lixte Biotechnology Holdings, Inc. of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $2.92 ( 1.10%) | $2.89 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for LIXT
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.05 | 5.55 % | |
| R2 | 3.00 | 3.85 % | ||
| R1 | 2.97 | 2.80 % | ||
| Current price: | 2.89 | |||
| Support | S1 | 2.87 | -0.597 % | |
| S2 | 2.84 | -1.65 % | ||
| S3 | 2.79 | -3.34 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.52 | 21.80 % | |
| R2 | 3.38 | 16.96 % | ||
| R1 | 3.31 | 14.53 % | ||
| Current price | 2.89 | |||
| Support | S1 | 2.70 | -6.75% | |
| S2 | 2.67 | -7.61% | ||
| S3 | 2.21 | -23.53% |
FAQ
Click here for our free guide on how to buy Lixte Biotechnology Holdings, Inc. Stock.
